NCT01836042View on ClinicalTrials.gov

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Primary Open Angle Glaucoma
Trial Locations (26)

15122

Pittsburgh

15825

Brookville

19107

Philadelphia

27101

Winston-Salem

30260

Morrow

33176

Miami

33426

Boynton Beach

33603

Tampa

40206

Louisville

45242

Cincinnati

46260

Indianapolis

49085

Saint Joseph

55431

Bloomington

55435

Edina

64055

Independence

64133

Kansas City

66213

Overland Park

70806

Baton Rouge

77702

Beaumont

80134

Parker

89121

Las Vegas

90210

Beverly Hills

92673

San Clemente

93454

Santa Maria

94954

Petaluma

95817

Sacramento

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY

NCT01836042 - Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort | Biotech Hunter | Biotech Hunter